Albumin-Bilirubin Grade and Hepatocellular Carcinoma Treatment Algorithm

J.-F. Blanc, Stephen L. Chan, J.O. Park, Baek‐Yeol Ryoo, Chung‐Jen Yen, Masatoshi Kudo, Rtp Poon, Davide Pastorelli, Ari David Baron, Tatiana Pfiffer, Takuji Okusaka, Kateřina Kubáčková, Jörg Trojan, Javier Sastre, Ian Chau, Paolo Abada,

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1159/000462199
Year: 2017
Published: —
Language: en

Editorial Material Details

Volume: 6
Issue: 3
Link Of The Paper: https://doi.org/10.1159/000462199

Timeline

Created:June 19, 2026

Samuel Chang,

Ling Yang,

Alice Zhu

Article2018

Usefulness of newly proposed albumin-bilirubin grade and its modification -Japan nationwide survey

Atsushi Hiraoka, Kojiro Michitaka, Takashi Kumada, Nobuhiro Izumi, M Kadoya, N. Kokudo, Shoji Kubo, Yoshinori Matsuyama, O Nakashima, Masaru Sakamoto, T. Takayama, Takashi Kokudo, Kenji Kashiwabara, Masatoshi Kudo

Article2023

Albumin-Bilirubin Grade Analyses of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: A Post Hoc Analysis of the Phase III IMbrave150 Study

Masatoshi Kudo, Richard S. Finn, Ann‐Lii Cheng, Andrew X. Zhu, Michel Ducreux, Peter R. Galle, Naoya Sakamoto, Naoya Kato, Michitaka Nakano, Jing Jia, Arndt Vogel

Article2004

Treatment of hepatocellular carcinoma

Josep M. Llovet

Current Treatment Options in Gastroenterology

Article2021

Prognostic grade for resecting hepatocellular carcinoma: multicentre retrospective study

Tadatoshi Takayama, Shintaro Yamazaki, Yutaka Matsuyama, Yutaka Midorikawa, Shuichiro Shiina, Namiki Izumi, Kiyoshi Hasegawa, Norihiro Kokudo, Michiie Sakamoto, Shoji Kubo, Masatoshi Kudo, Takamichi Murakami, O Nakashima